Pharmagen, Inc. distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company sources and distributes specialty drugs, blood plasma derivatives, specialty products, vaccines, anti-infectives, and hard-to-find pharmaceuticals. It offers plasma derivatives for treating serious medical conditions, such as cancer, hemophilia, rheumatoid arthritis, multiple scleroses, blood disorders, hepatitis, and HIV; and specialty products for treating respiratory, oncology, cardiovascular, and hormonal syndromes. The company also manufactures and distributes health supplements, including Clotamin, a specialized over-the-counter multivitamin dietary supplement for patients on Warfarin. In addition, it sells traditional pharmaceuticals to its distribution customers, such as antibiotics, vaccines, and other oral and injectable pharmaceuticals; and specializes in the formulation of drugs. The company was formerly known as Sunpeaks Ventures, Inc. and changed its name to Pharmagen, Inc. in January 2013. Pharmagen, Inc. is based in Silver Spring, Maryland.

Nome	Capitalizzazione di mercato
Itonis, Inc.	0M
Medlive Technology Co., Ltd.	0M
Patterson Companies, Inc.	0M
MediPal Holdings Corporation	0M
Medios AG	0M
Uniphar plc	0M
PT Enseval Putera Megatrading Tbk.	0M
Shanghai Pharmaceuticals Holding Co., Ltd	0M
Synergy CHC Corp.	0M
EBOS Group Limited	0M
Yamashita Health Care Holdings,Inc.	0M

Pharmagen, Inc.

Pharmagen, Inc. Elenco dei concorrenti

Principali concorrenti